Download FREE Report Sample
Download Free sampleCabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
Cabazitaxel Market contains market size and forecasts of Cabazitaxel in global, including the following market information:
Global Cabazitaxel Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cabazitaxel Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Cabazitaxel companies in 2021 (%)
The global Cabazitaxel market was valued at 209.4 million in 2021 and is projected to reach US$ 296.1 million by 2028, at a CAGR of 5.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity above 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cabazitaxel include Sanofi, Tapi Teva, Fuan Pharmaceutical Group and Fujian Yewpark Biological, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cabazitaxel manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cabazitaxel Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Cabazitaxel Market Segment Percentages, by Type, 2021 (%)
Purity above 99%
Other Purity
Global Cabazitaxel Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Cabazitaxel Market Segment Percentages, by Application, 2021 (%)
Age Below 65
Age Above 65
Global Cabazitaxel Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Cabazitaxel Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cabazitaxel revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cabazitaxel revenues share in global market, 2021 (%)
Key companies Cabazitaxel sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Cabazitaxel sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
